Abstract 1131: Preventive effect of Celecoxib in Sorafenib-related hand-foot syndrome in hepatocellular carcinoma patients, a single-center, open-label, randomized, controlled clinical phase III trial - KIVIRID

Abstract 1131: Preventive effect of Celecoxib in Sorafenib-related hand-foot syndrome in hepatocellular carcinoma patients, a single-center, open-label, randomized, controlled clinical phase III trial

Authors: JIANCONG CHEN

Published: 2020-09-04

DOI: 10.1158/1538-7445.am2020-1131

Source: Full article

Abstract

Abstract